Archives

by in
Entry Author Date Location
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies 05/16/13 San Diego
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
AnaptysBio Gets $1.5M from DARPA 07/12/10 San Diego
Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics 10/22/08 San Diego
Page 1 of 1